INNATE PHARMA logo

INNATE PHARMA

3 Marks
Corp.
First Filed:Oct 21, 2021Latest Filed:Apr 12, 2023Address:117 AVENUE DE LUMINY, MARSEILLE, 13009, FR

Portfolio Overview

Top Classes

Class 5
Pharmaceuticals
2(67%)
Class 1
Industrial Chemicals & Adhesives
1(33%)

TTAB Proceedings

No litigation activity

Top Firms

Loading...

Trademark Portfolio

3 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
KIRTAMSY
KIRTAMSY
Trademark
Word
REGISTERED
Owner:
Serial:79373551
Filed:Apr 12, 2023
Classes:5
Registration:7546739
Registered:Oct 29, 2024
Goods & Services
Pharmaceutical preparations for the treatment of cancer, immunoproliferative disorders, inflammatory disorders and autoimmune disorders, hematological malignancies, lymphomas, T-cell lymphomas, cutaneous T cell lymphomas, Sezary Syndrome and Mycosis fungoides.
LONKIRLO
LONKIRLO
Trademark
Word
REGISTERED
Owner:
Serial:79373552
Filed:Apr 12, 2023
Classes:5
Registration:7546740
Registered:Oct 29, 2024
Goods & Services
Pharmaceutical preparations for the treatment of cancer, immunoproliferative disorders, inflammatory disorders and autoimmune disorders, hematological malignancies, lymphomas, T-cell lymphomas, cutaneous T cell lymphomas, Sezary Syndrome and Mycosis fungoides.
ANKET
ANKET
Trademark
Word
REGISTERED
Owner:
Serial:97085429
Filed:Oct 21, 2021
Classes:1
Registration:6952905
Registered:Jan 17, 2023
Goods & Services
Chemical or biotechnological products for industry and science, namely, polypeptides and proteins; biological preparations, in particular antibodies in the nature of monoclonal antibodies, bispecific antibodies or multifunctional antibodies, antibody derivatives in the nature of antibody fragments, single-chain variable fragments, di-scFv, light and heavy chains of antibodies, binding proteins and peptides having a binding affinity to immune cells in the nature of T-cell engagers or NK-cell engagers, for laboratory and experimental purposes, in particular for conducting experimental tests other than for medical use; Biochemicals, namely, polypeptides for in vitro research use | Pharmaceuticals, medical, biological or biochemical preparations, substances for the treatment of diseases, as well as preparations for medical treatments, in particular, antibodies and derivatives being monoclonal antibodies, bispecific antibodies, multispecific antibodies, antibody fragments, single-chain variable fragments, di-scFv or light and heavy chains of antibodies for medical purposes, bifunctional or multifunctional proteins being T-cell engagers or NK cell engagers for medical purposes with binding affinity to immune cells, in particular NK cells, and other reagents for the diagnosis, prevention, monitoring and treatment of diseases, in particular cancers, infectious diseases, inflammatory diseases, and other immune pathologies | Scientific and technological services, namely, research and development in scientific and medical matters, in particular in the field of immunotherapy; scientific and technological services, namely, scientific research and development related to diagnostic products; pharmaceutical and biotechnological scientific laboratory services; laboratory research, analysis, evaluation, development and clinical trial of therapeutic compositions and treatments in the field of oncology; all of the above services concerning the use of antibodies, antibody derivatives, proteins, or other agents for activating or modulating natural and adaptive immunity